Edwards Larry Todd bought ARQT
February 27, 2026 · Form 4 insider transaction
Edwards Larry Todd bought 77,000 shares of Arcutis Biotherapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Acquired (buy-side)
Shares
77,000
Price
$0.00
Total value
N/A
InsiderEdwards Larry Todd
Role—
SecurityStock Option (right to buy)
Transaction codeA: Grant or award
Transaction dateFebruary 27, 2026
Filing dateMarch 3, 2026
Shares owned after77,000
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
1/48th of the shares subject to the option vest on each monthly anniversary measured from March 1, 2026 (the "Vesting Commencement Date"), such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service to the Issuer.